Somerville, MA, United States of America

Peter U Park

This inventor holds 33 USPTO granted patents and 25 published patent applications, plus 6 CIPO patents and 6 EPO patents, primarily in Bicyclic Peptide Ligands. Top assignees: Bicycletx Limited, Immunogen, Inc., Mersana Therapeutics, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter U Park. Retrieved from https://idiyas.com/inventor/peter-u-park

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33 (Patent Applications = 25)

% Patents Active = 75.8

CIPO Patents = 6 (Patent Applications = 10)

EPO Patents = 6 (Patent Applications = 21)

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 243(Granted Patents)

Location History:

Waltham, MA (US) (2016)
Somerville, MA (US) (2012 - 2022)
Lexington, MA (US) (2022 - 2023)
Lincoln, MA (US) (2020 - 2024)

Company Filing History:

Mersana Therapeutics, Inc.

patents

4. 4 out of 22

Debiopharm International, S.a.

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Bicyclic Peptide Ligands

Immunoconjugates

Cancer Treatment

Monoclonal Antibodies

CD37-Binding Molecules

HER2 Epitope

Nectin-4

OX40

NaPi2b

EGFR-Binding Molecules

Antitumor Combinations

Protein-Polymer-Drug Conjugates

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630588 - BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR CD137 (2026-05-19),

2. 12559566 - CD37-BINDING MOLECULES IMMUNOCONJUGATES THEREOF (2026-02-24),

3. 12459974 - Bicyclic peptide ligands specific for Nectin-4 (2025-11-04),

4. 12378288 - Multimeric bicyclic peptide ligands (2025-08-05),

5. 12049520 - Bicyclic peptide ligands specific for CD137 (2024-07-30),

6. 11912792 - Bicyclic peptide ligands specific for nectin-4 (2024-02-27),

7. 11613560 - Bicyclic peptide ligands specific for OX40 (2023-03-28),

8. 11542304 - Multimeric bicyclic peptide ligands (2023-01-03),

9. 11518812 - Monoclonal antibodies against HER2 epitope and methods of use thereof (2022-12-06),

10. 11466095 - CD37-binding molecules and immunoconjugates thereof (2022-10-11),

11. 11453703 - Heterotandem bicyclic peptide complexes (2022-09-27),

12. 11453702 - Bicyclic peptide ligands specific for Nectin-4 (2022-09-27),

13. 11414488 - Methods for treating cancer (2022-08-16),

14. 11261214 - Bicyclic peptide ligand specific for CD137 (2022-03-01),

15. 11180531 - Bicyclic peptide ligands specific for Nectin-4 (2021-11-23),

Title: The Innovative Journey of Peter U Park

Introduction: Peter U Park, a talented inventor based in Somerville, MA, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Peter U Park's latest patents include a cutting-edge wearable device for monitoring health metrics in real-time and a revolutionary software application for enhancing cybersecurity measures.

Career Highlights: With a career spanning over two decades, Peter U Park has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has been recognized with numerous awards and accolades in the industry.

Collaborations: Throughout his career, Peter U Park has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Peter U Park's passion for innovation and his relentless pursuit of excellence continue to drive him towards creating technologies that have the potential to shape the future. His dedication to pushing the boundaries of what is possible makes him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.